aHR	Adjusted Hazard Ratio
AF	Atrial Fibrillation
ADT	Androgen Deprivation Therapy
aOR	Adjusted Odds Ratio
BMI	Body Mass Index
CI	Confidence Interval
CKD	Chronic Kidney Disease
CVD	Cardiovascular Disease
CVE	Cardiovascular Event
CVm	Cardiovascular Mortality
DM	Diabetes Mellitus
GLP-1	Glucagon-Like Peptide-1
HbA1c	Hemoglobin A1c
HLD	Hyperlipidemia
HF	Heart Failure
HR	Hazard Ratio
HTN	Hypertension
IQR	Interquartile Range
IS	Ischemic Stroke
LDL	Low-Density Lipoprotein
MetAb-Pro	Metformin and Abiraterone Study in Prostate Cancer
NCI	National Cancer Institute
NHB	Non-Hispanic Black
NHW	Non-Hispanic White
PAD	Peripheral Artery Disease
PC	Prostate Cancer
PCsm	Prostate Cancer-Specific Mortality
SD	Standard Deviation
SDOH	Social Determinants of Health
SEER	Surveillance, Epidemiology, and End Results
SES	Socioeconomic Status
sHR	Subdistribution Hazard Ratio
SGLT2	Sodium-Glucose Cotransporter-2